Risk Factors for Lung Function Decline in Pediatric Asthma under Treatment: A Retrospective, Multicenter,

Shingo Yamada1, Takao Fujisawa2, Mizuho Nagao1

  • 1Allergy Center, National Hospital Organization Mie National Hospital, Tsu 514-0125, Japan.

Insights

Poor asthma control and long-acting beta2 agonist use are linked to declining lung function in children. Inhaled corticosteroid use, particularly at higher doses, is associated with better lung function trajectories in pediatric asthma patients.

Area of Science:

  • Pediatric Pulmonology
  • Asthma Research
  • Lung Function Development

Background:

  • Childhood asthma significantly impacts long-term lung function.
  • Factors contributing to poor lung function during childhood asthma treatment remain unclear.

Purpose of the Study:

  • To identify clinical factors associated with low or declining lung function in children undergoing asthma treatment.
  • To analyze lung function trajectories from childhood through adolescence.

Main Methods:

  • Longitudinal study of 273 children with asthma aged 6–15 years across seven Japanese hospitals.
  • Evaluation of forced expiratory volume in 1 second (FEV1) % predicted values and linear regression slopes to define lung function trajectories (Normal, Low, Upward, Downward).
  • Logistic regression analysis to compare factors associated with favorable (Normal/Upward) versus unfavorable (Low/Downward) lung function groups.

Main Results:

  • 72% of patients showed favorable lung function trajectories (Normal/Upward), while 28% had unfavorable ones (Low/Downward).
  • Unfavorable outcomes were linked to a history of poor asthma control, long-acting beta2 agonist use, and lower height Z-scores during adolescence.
  • Favorable outcomes correlated with inhaled corticosteroid (ICS) use during pre-adolescence and high-dose ICS use during adolescence.

Conclusions:

  • Several clinical factors predict lung function trajectories in pediatric asthma.
  • Monitoring asthma control, ICS dosage, and long-acting beta2 agonist use is crucial for managing pediatric lung function.
  • Early and consistent ICS treatment may be key to maintaining optimal lung function in children with asthma.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.6K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
552
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
414
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
523